Connect with us

Blood Warmer Devices Market: A Deep Dive Into Factors that will Help Vendors Stay Ahead of Competitors – Technavio

Blood Warmer Devices Market: A Deep Dive Into Factors that will Help Vendors Stay Ahead of Competitors – Technavio
PR Newswire
NEW YORK, Sept. 15, 2022

Vendors are deploying organic and inorganic growth strategies to compete in the market
NEW YORK,…

Published

on

Blood Warmer Devices Market: A Deep Dive Into Factors that will Help Vendors Stay Ahead of Competitors - Technavio

PR Newswire

Vendors are deploying organic and inorganic growth strategies to compete in the market

NEW YORK, Sept. 15, 2022 /PRNewswire/ -- One of the key vendors operating in the blood warmer devices market is Barkey GmbH and Co. KG. The company offers ranger blood fluid warming unit, which is designed to provide warm fluid to patients during operation. The market also has the presence of a few other major players, such as Becton Dickinson and Co., BIEGLER GmbH, EMIT Corp., Estill Medical Technologies Inc., and Gentherm Inc.

Challenges Faced by Blood Warmer Devices Market Vendors

The blood warmer devices market is fragmented. The market is highly competitive, with the presence of well-established vendors. The development and manufacturing of blood warmer devices are complex and cost-intensive. Hence, new players are not expected to enter the market easily.

Key Vendor Strategies to Overcome Market Challenges

Key strategies used by vendors to overcome the above challenges have been identified by Technavio. Vendors should heavily invest in innovative technologies for developing efficient and high-performance blood warmer devices for customers to stay ahead of their competitors.

Technavio's reports provide key strategic initiatives used by vendors, along with key news and the latest developments. View our FREE PDF Sample Report Now

Market Growth Potential

The blood warmer devices market size is expected to grow by USD 366.99 million from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 7.54% during the forecast period.

Technavio provides a comprehensive report summary describing the market size and forecast along with research methodology. The sample report is available in PDF format

Factors that will Drive the Market

Vendors in the blood warmer devices market can take advantage of a few factors that will work in their favor. The increasing prevalence of hypothermia is one of these factors. In the US, approximately 67% of hypothermia-related deaths are seen among males annually due to excessive natural cold. Blood warmer devices are used for reducing the risk of hypothermia that is associated with the infusion of cold blood products. Hypothermia can be caused by environmental exposure, the opening of body cavities, infusion of cold fluids and blood, and impaired thermos regulatory control. Blood warmer devices help in keeping the blood warm and maintain a normal temperature. Hence, the global blood warmer devices market is expected to witness high growth during the forecast period.

Technavio has identified key trends, drivers, and challenges in the market, which will help vendors improve their strategies to stay ahead of their competitors. View our FREE PDF Sample Report

Related Reports

Home Blood Pressure Monitoring Devices Market by Type and Geography - Forecast and Analysis 2022-2026: Factors such as the presence of a large undiagnosed population may impede market growth.

Blood Viscometer Market by End-user and Geography - Forecast and Analysis 2022-2026: Factors such as the high cost of blood viscometers may impede market growth.

Blood Warmer Devices Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 7.54%

Market growth 2022-2026

USD 366.99 million

Market structure

Fragmented

YoY growth (%)

6.97

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 42%

Key consumer countries

US, Germany, UK, Japan, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Barkey GmbH and Co. KG, Becton Dickinson and Co., BIEGLER GmbH, EMIT Corp., Estill Medical Technologies Inc., Gentherm Inc., ICU Medical Inc., LIFE WARMER, MEQU, SARSTEDT AG and Co. KG, Sino Medical Device Technology Co. Ltd., Smisson Cartledge Biomedical LLC, Stihler Electronic GmbH, Stryker Corp., The Surgical Co., Vyaire Medical Inc., 3M Co., and Belmont Medical Technologies

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse Health Care Market Reports

Table of Contents

1 Executive Summary

  • 1.1 Market overview 
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem 
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition 
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis 
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026 
    • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
    • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
    • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
    • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary 
    • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers 
    • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers 
    • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants 
    • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes 
    • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry 
    • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
  • 4.7 Market condition 
    • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

  • 5.1 Market segments 
    • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
    • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
  • 5.2 Comparison by Product 
    • Exhibit 26: Chart on Comparison by Product
    • Exhibit 27: Data Table on Comparison by Product
  • 5.3 Blankets and accessories - Market size and forecast 2021-2026 
    • Exhibit 28: Chart on Blankets and accessories - Market size and forecast 2021-2026 ($ million)
    • Exhibit 29: Data Table on Blankets and accessories - Market size and forecast 2021-2026 ($ million)
    • Exhibit 30: Chart on Blankets and accessories - Year-over-year growth 2021-2026 (%)
    • Exhibit 31: Data Table on Blankets and accessories - Year-over-year growth 2021-2026 (%)
  • 5.4 Systems - Market size and forecast 2021-2026
    • Exhibit 32: Chart on Systems - Market size and forecast 2021-2026 ($ million)
    • Exhibit 33: Data Table on Systems - Market size and forecast 2021-2026 ($ million)
    • Exhibit 34: Chart on Systems - Year-over-year growth 2021-2026 (%)
    • Exhibit 35: Data Table on Systems - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Product 
    • Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview 
    • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation 
    • Exhibit 38: Chart on Market share by geography 2021-2026 (%)
    • Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
  • 7.2 Geographic comparison 
    • Exhibit 40: Chart on Geographic comparison
    • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
    • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
    • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
    • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
    • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
    • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
    • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
    • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
    • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
    • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
    • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
    • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
    • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
    • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
    • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
    • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
    • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
    • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
    • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
    • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
    • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
    • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
    • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
    • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 Japan - Market size and forecast 2021-2026
    • Exhibit 66: Chart on Japan - Market size and forecast 2021-2026 ($ million)
    • Exhibit 67: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
    • Exhibit 68: Chart on Japan - Year-over-year growth 2021-2026 (%)
    • Exhibit 69: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • 7.10 China - Market size and forecast 2021-2026
    • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
    • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
    • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
    • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.11 UK - Market size and forecast 2021-2026
    • Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
    • Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
    • Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
    • Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity by geography 
    • Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges 
    • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape 
    • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption 
    • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks 
    • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered 
    • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors 
    • Exhibit 84: Matrix on vendor position and classification
  • 10.3 3M Co. 
    • Exhibit 85: 3M Co. - Overview
    • Exhibit 86: 3M Co. - Business segments
    • Exhibit 87: 3M Co. - Key news
    • Exhibit 88: 3M Co. - Key offerings
    • Exhibit 89: 3M Co. - Segment focus
  • 10.4 Barkey GmbH and Co. KG 
    • Exhibit 90: Barkey GmbH and Co. KG - Overview
    • Exhibit 91: Barkey GmbH and Co. KG - Product / Service
    • Exhibit 92: Barkey GmbH and Co. KG - Key offerings
  • 10.5 Becton Dickinson and Co. 
    • Exhibit 93: Becton Dickinson and Co. - Overview
    • Exhibit 94: Becton Dickinson and Co. - Business segments
    • Exhibit 95: Becton Dickinson and Co. - Key news
    • Exhibit 96: Becton Dickinson and Co. - Key offerings
    • Exhibit 97: Becton Dickinson and Co. - Segment focus
  • 10.6 Belmont Medical Technologies 
    • Exhibit 98: Belmont Medical Technologies - Overview
    • Exhibit 99: Belmont Medical Technologies - Product / Service
    • Exhibit 100: Belmont Medical Technologies - Key offerings
  • 10.7 Estill Medical Technologies Inc. 
    • Exhibit 101: Estill Medical Technologies Inc. - Overview
    • Exhibit 102: Estill Medical Technologies Inc. - Product / Service
    • Exhibit 103: Estill Medical Technologies Inc. - Key offerings
  • 10.8 Gentherm Inc. 
    • Exhibit 104: Gentherm Inc. - Overview
    • Exhibit 105: Gentherm Inc. - Business segments
    • Exhibit 106: Gentherm Inc. - Key news
    • Exhibit 107: Gentherm Inc. - Key offerings
    • Exhibit 108: Gentherm Inc. - Segment focus
  • 10.9 ICU Medical Inc. 
    • Exhibit 109: ICU Medical Inc. - Overview
    • Exhibit 110: ICU Medical Inc. - Product / Service
    • Exhibit 111: ICU Medical Inc. - Key offerings
  • 10.10 Sino Medical Device Technology Co. Ltd.
    • Exhibit 112: Sino Medical Device Technology Co. Ltd. - Overview
    • Exhibit 113: Sino Medical Device Technology Co. Ltd. - Product / Service
    • Exhibit 114: Sino Medical Device Technology Co. Ltd. - Key offerings
  • 10.11 Stryker Corp. 
    • Exhibit 115: Stryker Corp. - Overview
    • Exhibit 116: Stryker Corp. - Business segments
    • Exhibit 117: Stryker Corp. - Key news
    • Exhibit 118: Stryker Corp. - Key offerings
    • Exhibit 119: Stryker Corp. - Segment focus
  • 10.12 Vyaire Medical Inc. 
    • Exhibit 120: Vyaire Medical Inc. - Overview
    • Exhibit 121: Vyaire Medical Inc. - Product / Service
    • Exhibit 122: Vyaire Medical Inc. - Key news
    • Exhibit 123: Vyaire Medical Inc. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist 
    • Exhibit 124: Inclusions checklist
    • Exhibit 125: Exclusions checklist
  • 11.3 Currency conversion rates for US$ 
    • Exhibit 126: Currency conversion rates for US$
  • 11.4 Research methodology 
    • Exhibit 127: Research methodology
    • Exhibit 128: Validation techniques employed for market sizing
    • Exhibit 129: Information sources
  • 11.5 List of abbreviations 
    • Exhibit 130: List of abbreviations
About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/blood-warmer-devices-market-a-deep-dive-into-factors-that-will-help-vendors-stay-ahead-of-competitors--technavio-301624383.html

SOURCE Technavio

Read More

Continue Reading

International

Greenback Surges after BOJ Hikes and Ends YCC and RBA Delivers a Dovish Hold

Overview: The US dollar is surging today against
most of the G10 currencies, and although the intraday momentum is stretched
ahead of start of the North…

Published

on

Overview: The US dollar is surging today against most of the G10 currencies, and although the intraday momentum is stretched ahead of start of the North American session, there may be little incentive to resist before the end of the FOMC meeting tomorrow. The Bank of Japan's rate hike and the end of Yield Curve Control were not seen as the start of the tightening cycle. The two-year JGB yield slipped to a two-week low and settled below its 20-day moving average for the first time since mid-January. The Reserve Bank of Australia delivered a dovish hold by dropping the reference the future tightening. The yen (~-0.95%) and Australian dollar (~-0.85%) are the weakest of the G10 currencies. Emerging market currencies are lower, led by the Philippine peso (~-0.65%). The offshore yuan is weaker for the sixth consecutive session. 

Japanese, Australian, and New Zealand equities bucked the regional trend to advance today. Stoxx 600 in Europe is slightly lower, and if sustained, it would be the fourth consecutive losing session. That would be the long losing streak since last October. US index futures are nursing small losses. Ten-year JGB and Australian bond yield fell almost three basis points today. European benchmark yields are mostly slightly softer, though the periphery is lagging the core today. The US 10-year yield is little changed near 4.32%. The high for the year is near 4.35%. The US two-year yield did set a new high for the year yesterday near 4.75%. It is near 4.72% now. The greenback's strength is capping gold, which is trading inside yesterday's range and straddling the $2150 area. May WTI soared to $82.50 yesterday as its recent rally was extended amid Ukrainian strikes on Russian refiners. Diesel futures rose for the fourth consecutive session yesterday and gasoline futures extend its rally for a sixth session. May WTI is consolidating in a narrow range around $82. 

Asia Pacific

The Japanese press reports turned out to be fairly accurate: the Bank of Japan hiked its overnight target rate to 0%-0.1%. It scrapped the Yield Curve Control and confirmed it would stop buying ETFs. The one surprise was that the central bank indicated it would continue to purchase long-term bonds as needed. Governor Ueda, on one hand, said that the sustained 2% inflation target is not in hand, which sounded dovish. He also recognized that if the positive trends for wages and prices lift inflation expectations, and higher prices results, rate hikes may be necessary. The 10-year yield softened by almost three basis points (to ~0.73%). The Nikkei rallied 1%, and the yen was sold. The US dollar reached about JPY150.50.

As widely expected, the Reserve Bank of Australia left its cash target rate at 4.35%, where it has been since it was lifted by 25 bp last November. Economic activity has slowed, and price pressures are moderating, but the RBA seems to be in no hurry to unwind the November hike. Still, it dropped the reference to possible future hikes. The dovish hold sent the Australian dollar to a nine-day low near $0.6510. The futures market is not 100% confident the RBA will do so before September. However, the odds of an August cut have been marked up to around 97% from about 78% yesterday. 

The dollar is rising against the Japanese yen for the sixth consecutive session. It matches the longest advancing streak since last August and lifted the greenback to two-week highs near JPY150.70. The greenback approached JPY151 in mid-February through early March. The high from 2022 and 2023 was closer to JPY152. The intraday momentum indicators are stretched ahead of the North American open, but there may be little incentive to resist before tomorrow's FOMC meeting. What is being seen as a dovish hold by the RBA has sent the Australian dollar to nearly $0.6500. The trendline off the mid-February and early March lows comes in today a little below there. The low earlier this month was set slightly below $0.6480. The intraday momentum indicators are stretched. Initial resistance now is seen int he $0.6520-25 area. The greenback's gains, especially against the yen, have weighed on the Chinese yuan. The dollar is challenged the CNY7.20 cap that has not been violated this year. The PBOC set the dollar's reference rate at CNY7.0985 (CNY7.0943 yesterday). The Bloomberg average was CNY7.2020 (CNY7.1993 yesterday). The dollar is rising against the offshore yuan for the sixth consecutive session. It has reached CNH7.2130, its highest level in two weeks. The high for the year was set on February 14 near CNH7.2335.

Europe

The focus will not shift to Europe until Thursday. Three central banks meet then, Norway's Norges Bank, the Swiss National Bank, and the Bank of England. It is true the UK sees February CPI tomorrow. The year-over-year rate is expected to fall toward 3.5% from 4.0% and the core rate is seen falling to 4.6% from 5.1%. The UK's three-month annualized rate may near 2% and the six-month annualized increase maybe around 1.6%. Still, the market does not expect the BOE or the other west European central banks to change policy. Still, we suspect the risk is for a SNB move to get ahead of the ECB. The macro backdrop is conducive for a move with softer growth and low inflation. 

The March ZEW survey in Germany showed a little improvement. The assessment of the current situation remains poor. It edged up to -80.5 from -81.7. At its worst, during the pandemic, it fell to -93.5 in May 2020. It had recovered and peaked at 21.6 in October 2021, and had already begun weakening again before Russia's invasion of Ukraine. It was at -10.2 in January 2022. The expectations component is a different story. It rose for the eighth consecutive month to 31.7, which is the highest reading since February 2022. The high last year was set in February at 28.1.

The euro met sellers in the US morning yesterday as it pushed above $1.09. The selling knocked it down to new session lows near $1.0865 It has been sold to $1.0835 today, around where the (50%) retracement of the rally from the February 14 lows and the 200-day moving average are found. A break of this area targets $1.08. Note that in the futures market, the non-commercial (speculative) net long euro position has risen by 50% since the mid-February low through March 12 that is covered by the most recent CFTC report. Meanwhile, the non-commercial net long sterling position has risen every week this year but one, and at nearly 70.5k contracts (GBP62.5k per contract or almost $5.6 bln position), it is the largest net long position since 2007. Sterling extended its losses yesterday to nearly $1.2715, and has been sold to almost $1.2665 today, the lowest level since March 4. The $1.2670 area corresponds to the (61.8%) retracement of the recovery off the year's low set on February 14 near $1.2535. The intraday momentum indicators are stretched, but there is little chart support ahead of $1.2600.

America

The focus, of course, is on tomorrow's Fed meeting. No one expects the Fed to do anything. It is more about what the Fed says, and here, the dot plot is important. Keen interest is in the number of rates cuts the median dot signals. Three cuts were signaled in December. While CPI and PPI were slightly above market expectations, we do not think that they deviated much from what the Fed anticipated. To us, a key consideration is Fed Chair Powell's acknowledgement that officials did not need to see better data to boost their confidence that inflation was headed back to target. It just needed to see good data. Other macro forecasts may be tweaked. The 4.1% unemployment rate anticipated for this year looks low. It was at 3.9% in February. The median dot was for the headline and core PCE deflator to be at 2.4% at the end of the year. They stood at 2.4% and 2.8%, respectively in January and are expected to be unchanged when the February series is reported next week. The median dot in December was for the economy to grow 1.4% this year. The median forecast in Bloomberg's monthly survey was for 2.1% growth, which is the same as the IMF's projection. On tap today, February housing starts and permits, which are expected to tick up after weather-related weakness in January.

Canada reports February CPI today. Given the base effect, the 0.6% median forecast in Bloomberg's survey translates into a 3.1% year-over-year rate. It was at 2.9% in January. The low print in 2023 was in June at 2.8%. The underlying core measures are expected to be flat. The swaps market has about a 50% chance of a cut in June. It nearly fully discounted on March 5, the day before the Bank of Canada met. The summary of its deliberations will be published tomorrow. The market has about 60 bp of cuts discounted for this year, which is two quarter-point moves and around a 40% chance of a third. A 100 bp of cuts was fully discounted as recently as February 20.

The US dollar hovered around little changed levels against the Canadian dollar yesterday. Neither rising US equities (risk-on) nor an extension of oil's rally did much for the Canadian dollar. Resistance near CAD1.3550 has been overcome today and it the greenback looks poised to re-test the CAD1.36 area that capped the greenback in late February and earlier this month. A band of resistance extends toward CAD1.3620-25. Yesterday, the US dollar rose for the third consecutive session against the Mexican peso, which matches the longest advance in six months. The nearly 0.9% rally was the most since mid-January. Mexico was on holiday yesterday and the thin markets may have exacerbated the move. The US dollar rose to a six-day high of almost MXN16.87. This effectively recouped nearly half of the greenback's losses this month. Today, the dollar is approaching the next retracement (61.8%) and the 20-day moving average are near MXN16.93. Brazil was not closed and fell for the third consecutive session. In fact, the dollar poked above BRL5.03, its highest level since last November 1. Nearly all emerging market currencies fell yesterday. The South African rand (~-0.95%) was the weakest followed by the Mexican peso (~0.75%). Emerging market currencies are no match for the dollar's surge today. The MSCI Emerging Market Currency Index is off for the fifth consecutive session. 


Disclaimer 

Read More

Continue Reading

Uncategorized

When words make you sick

In a new book, experts in a variety of fields explore nocebo effects – how negative expectations concerning health can make a person sick. It is the…

Published

on

In a new book, experts in a variety of fields explore nocebo effects – how negative expectations concerning health can make a person sick. It is the first time a book has been written on this subject.

“I think it’s the idea that words really matter. It’s fascinating that how we communicate can affect the outcome. Communication in health care is perhaps more important than the patient recognises,” says Charlotte Blease, who is a researcher at the Department of Women’s and Children’s Health at Uppsala University. 
Along with colleagues at Brown University in the United States and the University of Zurich in Switzerland she has written the book “The Nocebo Effect: When Words Make You Sick”. Nocebo is sometimes called the placebo’s evil twin. A placebo effect occurs when a patient thinks they feel better because of receiving medicine and part of that perception is due not to the drug but to positive expectations. The concept of the nocebo effect means that harmful things can happen because a person expects it – unconsciously or consciously. This is the first time the phenomenon has been addressed in a scholarly book. Researchers in medicine, history, culture, psychology and philosophy have examined it, each in their own particular area. 

Credit: Catherine Blease

In a new book, experts in a variety of fields explore nocebo effects – how negative expectations concerning health can make a person sick. It is the first time a book has been written on this subject.

“I think it’s the idea that words really matter. It’s fascinating that how we communicate can affect the outcome. Communication in health care is perhaps more important than the patient recognises,” says Charlotte Blease, who is a researcher at the Department of Women’s and Children’s Health at Uppsala University. 
Along with colleagues at Brown University in the United States and the University of Zurich in Switzerland she has written the book “The Nocebo Effect: When Words Make You Sick”. Nocebo is sometimes called the placebo’s evil twin. A placebo effect occurs when a patient thinks they feel better because of receiving medicine and part of that perception is due not to the drug but to positive expectations. The concept of the nocebo effect means that harmful things can happen because a person expects it – unconsciously or consciously. This is the first time the phenomenon has been addressed in a scholarly book. Researchers in medicine, history, culture, psychology and philosophy have examined it, each in their own particular area. 

“It’s a very new field, an emerging discipline. Even if the nocebo effect is documented far back in history, it perhaps became especially obvious during the coronavirus pandemic,” Blease says.

A previous study of patients during the pandemic (see below) shows that as many as three quarters of the reported side-effects of the coronavirus vaccine may be due to the nocebo effect. The study involved more than 45,000 participants, approximately half of whom were injected with a saline solution instead of the vaccine but despite this still experienced many side-effects such as nausea and headache. In the book, the authors highlight that one issue that disappeared in the discussion of side-effects during the coronavirus pandemic was that many of these were actually due to the nocebo effect.

“Whether this is due to expectations – the nocebo effect – remains to be understood. However, it is curious that so many participants reported side-effects after receiving no vaccine. Regardless, some people may have been put off by what they heard about side-effects,” Blease comments.


Read More

Continue Reading

International

Anti-Semitism As The Harbinger Of Global Chaos

Anti-Semitism As The Harbinger Of Global Chaos

Authored by Stephen Soukup via American Greatness,

On the off chance you hadn’t noticed,…

Published

on

Anti-Semitism As The Harbinger Of Global Chaos

Authored by Stephen Soukup via American Greatness,

On the off chance you hadn’t noticed, the world appears to be at an especially precarious moment presently. Obviously, war continues to rage in Ukraine and Gaza, with no end in sight to either conflict. Great Britain and Japan are currently in recession. Canada’s economy is an absolute disaster, with almost no hope of near-term recovery. Much of continental Europe and China are struggling economically, if not officially contracting. Some experts believe that the global economy more generally is sliding, slowly but surely, into recession. The only economic bright spot in the world is the United States, and even here we have our problems with consumer spending and sentiment, massive credit concerns, and inarguably sticky inflation.

Meanwhile, China is investing in and winning friends, and influencing people in the Global South. U.S.-backed Kurdish leaders are warning that ISIS is resurgent in Syria and Iraq. The Marine general in charge of U.S. Africa Command is warning of Russia’s increasing influence on that continent. Sudan remains mired in civil war. Nigeria is plagued by Islamist terrorism and mass kidnappings. Mexico is in the midst of a full-blown war with the drug cartels, who continue to grow bolder and more militarily sophisticated.

Everywhere one looks, chaos reigns—or, at the very least, bubbles just below the surface.

Perhaps most telling among the signs of disarray is the unnerving rise of antisemitism in the United States, Europe, and throughout the world. Antisemitism, in general, has been intensifying, slowly but surely, over the last decade or so. Over the last few months, however, it has emerged fully into the open, undaunted and unembarrassed. What was once considered shameful and disconcerting is now warmly welcomed as a “rational” response to American foreign policy, Israeli war practices, “colonialism,” and “white privilege.”

All of this is troubling, to put it mildly, both in and of itself and as a harbinger of greater and more deadly global unrest.

Hatred of and anger toward Jews is not the same as other forms of bigotry.  

In many ways, the history of Western anti-Jewish hatred mirrors the history of Western political chaos and collapse.  Or, to put it another way, historically, Jews are not only the perennial scapegoats during periods of social upheaval and displacement, but resurgent anti-Semitism serves as the proverbial canary in the coal mine for the rise of revolutionary movements.

In his classic, The Pursuit of the Millennium, the British historian Norman Cohn argues that the Jewish diaspora generally fit comfortably, if tentatively into European society for most of the first thousand years or so A.D., and only became a hated and perpetually persecuted minority with the rise of utopian Millenarianism that accompanied and then outlived the Crusades.  Beginning then and continuing for the next nearly a thousand years, Europeans came to associate Jews with the antichrist and thus to associate hatred and persecution of Jews with preparing the battlespace for the Second Coming.  Many historians, including Hannah Arendt, believed that the anti-Semitism that was such an integral part of the West’s 20th-century collapse into totalitarianism was relatively new and, in any case, distinct from medieval anti-Semitism.  Cohn’s history suggests otherwise, connecting the religious eschatology of medieval Europe to the quasi-religious eschatology of post-Enlightenment Europe, thereby connecting the persistence of Western anti-Semitism as well.

Cohn tells us that millenarian moments and the millenarian movements that capitalize on those moments all share a common group of characteristics. They all appear under certain social and economic conditions. They all appeal to a certain segment of the population at large, who then present themselves as economic, spiritual, and political leaders. They all utilize scapegoats, meaning that they all identify a different, usually much smaller segment of the population on whom they can blame all the world’s ills and then set about to cure those ills through the elimination of the scapegoat. And more often than not, that scapegoat tends to be Jewish.

In the conclusion to the second edition of Pursuit of the Millennium, Cohn notes that the millenarian fervor of the middle ages may have changed, but it never really died, and it maintained its common characteristics even as it became secular or “quasi-religious.” He wrote:

The story told in Pursuit of the Millennium ended some four centuries ago but is not without relevance to our own times. [I have] shown in another work [Warrant for Genocide: The Myth of the Jewish World Conspiracy and the Protocols of the Elders of Zion] how closely the Nazi phantasy of a world-wide Jewish conspiracy of destruction is related to the phantasies that inspired Emico of Leningrad and the Master of Hungary; and how mass disorientation and insecurity have fostered the demonization of the Jew in this as in much earlier centuries. The parallels and indeed the continuity are incontestable.

The parallels between the rise of Nazism and the current global unrest and demonization of the Jewish people are also largely incontestable. The election that brought Hitler to power didn’t happen in a vacuum, after all. It happened in the midst of global chaos, namely the Great Depression. It also followed the decadence and distortion of the Weimer Era. As the New York Fed has shown, even a global pandemic—the 1919 Spanish Flu outbreak—contributed to the sense of discomfort and disconnect among the German population, prompting increased support for Hitler and his Nazis.

The present global chaos doesn’t have to end the same way the chaos of a century ago did. It doesn’t have to result in the ascension of millenarian ideologies and their totalitarian defenders. History has shown that extremism can be short-circuited and radical ideologies undone. The first step in doing so, however, must be to bring an end to the rationalization of the persecution of the world’s Jews. The second step is to end the persecution itself.

Antisemitism is ugly and shameful, and it must be treated as such. For their sake and ours.

Tyler Durden Tue, 03/19/2024 - 02:00

Read More

Continue Reading

Trending